Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-004803-78Phase 2Completed
Phase 2, randomised, double-blind trial in Meniere Disease comparing Transtympanic methylprednisolone with Transtympanic gentamicin (2 arms). Primary endpoint: Relief from vertigo attacks. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-004803-78.